机译:乳腺癌分子靶向诊断和治疗策略的临床前研究
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Department of Radiology Clinical Research Institute National Hospital Organization Kyushu Medical Cancer Fukuoka Japan;
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Department of Pathology Kurume University Fukuoka Japan;
Department of Surgery Kurume University Asahimachi 67 Fukuoka 830-0011 Japan;
Center for Innovative Cancer Therapy of the 21st Century COE Program for Medical Science Kurume University Fukuoka Japan;
Breast cancer; Molecular targeting; Protein kinase C; Cap43; YB-1;
机译:一种针对激素依赖性乳腺癌的新治疗策略:双重芳香化酶和硫酸酯酶抑制剂的临床前开发。
机译:治疗肿瘤新诊断和治疗产品的治疗靶矿物的潜力:Progranulin / GP88作为乳腺癌和肺癌的治疗和诊断靶标
机译:更新乳腺癌2019第2部分 - 在临床实践中实施晚期乳腺癌患者的新型诊断和治疗方法
机译:优化多功能介孔二氧化硅纳米颗粒的形态,以提高乳腺癌的治疗和诊断效果
机译:肽受体靶向诊断和治疗放射性药物前列腺癌的合成与临床前评价
机译:白细胞介素-12在癌症治疗中的临床和临床前研究综述及白细胞介素-12在化学疗法中白细胞介素-12的保护作用
机译:乳腺癌分子靶向治疗策略的临床前与临床发展
机译:使用新的胚胎乳腺干细胞基因签名来改善人类乳腺癌诊断和治疗决策。